| Authors: |
Britaine R; Department of Ophthalmology, Bretonneau University Hospital of Tours, Tours, France. Electronic address: romain.britaine@etu.univ-tours.fr., Le Lez ML; Department of Ophthalmology, Bretonneau University Hospital of Tours, Tours, France., Valentin JB; CHRU Tours, Department of Hematology and Hemostasis, Tours, France; CHRU Tours, Reference center for sickle cell disease, thalassemia and other red cell disorders - Competence center (children), Tours, France; CHRU Tours, Reference center for sickle cell disease, thalassemia and other red cell disorders - Competence center (adults), Tours, France; CHRU Tours, Hematology-Hemostasis Laboratory, Tours, France; MCGRE - French rare diseases Healthcare Network: rare hemoglobinopathies, Créteil, France., Bens H; MCGRE - French rare diseases Healthcare Network: rare hemoglobinopathies, Créteil, France; CHRU Orléans, Department of Internal Medicine, Orléans, France., Aminata Conde M; MCGRE - French rare diseases Healthcare Network: rare hemoglobinopathies, Créteil, France; CHRU Orléans, Department of Pediatrics, Orléans, France., Serre J; CHRU Tours, Department of Onco-Hematology Pediatric, Tours, France., Pisella PJ; Department of Ophthalmology, Bretonneau University Hospital of Tours, Tours, France., Khanna RK; Department of Ophthalmology, Bretonneau University Hospital of Tours, Tours, France; University Hospital of Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032 Tours, France., Bernard Y; CHRU Orléans, Department of Ophthalmology, Orléans, France. |
